China Scar Treatment Market Is Driven by Increasing Road Accidents...

China Scar Treatment Market Is Driven by Increasing Road Accidents

Posted 2024-05-10 10:10:56

Scar treatment products refer to range of medical treatments used for reducing the appearance of scars. Some common scar treatments include topical creams, gels, silicone sheets, laser therapy, steroid injections and surgery. These treatments aids in improving skin texture, diminishing discoloration and reducing height and thickness of scars. The most common scarring conditions treated includes hypertrophic scars and keloids, surgery scars, acne scars and burn scars. China has witnessed significant increase in road accidents over last decade. As per WHO, road traffic accidents remained a leading cause of injury-related mortality in China. As scarring is common outcome of wounds from accidents, this has driven the demand for effective scar treatment options.

The Global China Scar Treatment Market is estimated to be valued at US$ 19.01 Mn in 2024 and is expected to exhibit a CAGR of 1.7% over the forecast period 2024 to 2031. Key players operating in the China scar treatment are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical.

Key Takeaways

Key players operating in the China Scar Treatment Market Growth are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. Medtronic Plc offers a wide range of scar treatment products including scar therapy gels, creams and sheets. LivaNova PLC manufactures laser surgery devices indicated for scar revision and resurfacing.

The demand for scar treatment products is growing in China owing to rising disposable income, awareness regarding aesthetic procedures and increasing preference for minimally invasive treatments. Various new product launches, celebrity endorsements and social media marketing is further propelling the demand.

China scar treatment market is witnessing increasing global investments and expansion of key players. Several companies are partnering with local Chinese manufacturers and hospitals to strengthen their distribution network in the country. Market leaders are actively engaging in new product development, manufacturing and promotional activities to gain higher market share.

Market Drivers
Increasing road accidents remains a key growth driver for China scar treatment market. As per estimates, around 260,000 deaths occur annually due to road crashes in China. Post-accident scarring has driven the demand for scar diminishing treatments. Moreover, rising superficial injuries from day to day life coupled with awareness about scar appearance has boosted the cosmetic procedures for scar revision. This in turn is propelling the sales of various scar treatment products in China.

Current geopolitical situation on China Scar Treatment Market:

The China Scar Treatment Market is facing challenges due to the complex geopolitical situation globally. The rising geopolitical tensions between major countries like US and China are impacting international trade and cooperation in the medical sector. Many Western companies are facing regulatory hurdles and policy restrictions while expanding in China. Furthermore, the ongoing Russia-Ukraine conflict and lockdowns in China due to its zero-Covid policy are disrupting global supply chains of key medical devices and drugs. This is affecting the timely availability of innovative scar treatment products in China.

To overcome such challenges, companies should focus on diversifying their manufacturing and supplier networks outside these regions. Localizing more production and establishing strategic partnerships with domestic Chinese firms can help gain approvals faster and ensure supply resilience. Companies also need to devise alternative marketing strategies involving online platforms to reach customers amid lockdowns or travel restrictions. Collaborating with local hospitals, dermatologists as well as influencers on Chinese social media can help create awareness. Over the long run, firms should invest more in R&D to develop cutting-edge made-in-China products customized for the needs of Chinese patients. This will make them less dependent on global supply networks vulnerable to geopolitical risks.

In terms of geographical concentration, value-wise, the China Scar Treatment Market is highly dominated by tier 1 cities like Beijing, Shanghai, Guangzhou and Shenzhen. These developed metropolitan regions account for over 60% of the overall market value due to higher affordability and adoption of advanced scar treatment therapies by residents. Hospital infrastructure as well availability of expert clinicians also support the market growth in these cities.

However, in terms of growth rate, tier 2 cities like Chengdu, Chongqing, Xi'an and Hangzhou offer higher potential. These emerging economic centres are witnessing rising incomes, growing medical infrastructure as well as increasing medical tourism and aesthetic procedures. Supported by government initiatives, growth rate in tier 2 cities is projected to be over 3% during the forecast period compared to around 2% in tier 1 cities. This makes them important targets for companies to tap future demand.